(Q40751753)

23 September 2017

title

Plasma renin activity in the emergency department and its independent association with acute myocardial infarction (English)

1 reference

23 September 2017

4

1 reference

23 September 2017

Blumenfeld JD

1

1 reference

23 September 2017

Sealey JE

2

1 reference

23 September 2017

Alderman MH

3

1 reference

23 September 2017

Lappin R

5

1 reference

23 September 2017

Catanzaro DF

6

1 reference

23 September 2017

Laragh JH

7

1 reference

23 September 2017

publication date

1 August 2000

1 reference

Journal of Clinical Hypertension

23 September 2017

published in

1 reference

23 September 2017

volume

13

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

855-863

1 reference

Essential hypertension: renin and aldosterone, heart attack and stroke.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Short- and long-term neurohormonal activation following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Effect of early captopril treatment on blood adrenaline levels in acute myocardial infarction (the substudy of ISIS-4). International Study of Infarct Survival-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Neuroendocrine activation after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Neuroendocrine changes post myocardial infarction: Effects of xamoterol

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Electrolyte metabolism and aldosterone secretion in benign and malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

High and low renin subgroups of essential hypertension: differences and similarities in their renin and sympathetic responses to neural and nonneural stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

The sympathetic nervous system in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

1 reference

7 January 2021

Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2800%2900277-6

7 January 2021

10.1016/S0895-7061(00)00277-6

Identifiers

DOI

1 reference

23 September 2017

1 reference